Epilepsy natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 28: Line 28:
** Soft tissue injury<ref name="pmid12199734">{{cite journal |vauthors=Beghi E, Cornaggia C |title=Morbidity and accidents in patients with epilepsy: results of a European cohort study |journal=Epilepsia |volume=43 |issue=9 |pages=1076–83 |date=September 2002 |pmid=12199734 |doi= |url=}}</ref>
** Soft tissue injury<ref name="pmid12199734">{{cite journal |vauthors=Beghi E, Cornaggia C |title=Morbidity and accidents in patients with epilepsy: results of a European cohort study |journal=Epilepsia |volume=43 |issue=9 |pages=1076–83 |date=September 2002 |pmid=12199734 |doi= |url=}}</ref>
** Motor vehicle accidents<ref name="pmid8404737">{{cite journal |vauthors=Hansotia P, Broste SK |title=Epilepsy and traffic safety |journal=Epilepsia |volume=34 |issue=5 |pages=852–8 |date=1993 |pmid=8404737 |doi= |url=}}</ref>
** Motor vehicle accidents<ref name="pmid8404737">{{cite journal |vauthors=Hansotia P, Broste SK |title=Epilepsy and traffic safety |journal=Epilepsia |volume=34 |issue=5 |pages=852–8 |date=1993 |pmid=8404737 |doi= |url=}}</ref>
** [[Epileptic Heart|Epileptic heart]]
** [[Epileptic Heart|Epileptic heart]]<ref name="VerrierPang2020">{{cite journal|last1=Verrier|first1=Richard L.|last2=Pang|first2=Trudy D.|last3=Nearing|first3=Bruce D.|last4=Schachter|first4=Steven C.|title=The Epileptic Heart: Concept and clinical evidence|journal=Epilepsy & Behavior|volume=105|year=2020|pages=106946|issn=15255050|doi=10.1016/j.yebeh.2020.106946}}</ref>
=== Prognosis ===
=== Prognosis ===
* Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
* Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
Line 34: Line 34:
* The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
* The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
* [Subtype of disease/malignancy] is associated with the most favorable prognosis.
* [Subtype of disease/malignancy] is associated with the most favorable prognosis.
* The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
* The prognosis varies with the [characteristic] of the tumor; [subtype of disease/malignancy] has the most favorable prognosis.


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WS}}


[[Category:Needs content]]
[[Category:Neurological disorders]]
[[Category:Neurological disorders]]
[[Category:Neurology]]
[[Category:Neurology]]

Revision as of 23:46, 13 January 2021

Epilepsy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Epilepsy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

EEG

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epilepsy natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Epilepsy natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epilepsy natural history, complications and prognosis

CDC on Epilepsy natural history, complications and prognosis

Epilepsy natural history, complications and prognosis in the news

Blogs on Epilepsy natural history, complications and prognosis

Directions to Hospitals Treating Epilepsy

Risk calculators and risk factors for Epilepsy natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

If left untreated, 23% to 71% of patients with a single unprovoked seizure may experience it again within 2 years. After the second unprovoked seizure, the chance of having another seizure increase to 73%. Recurrent seizures with no underlying illness emphasis on epilepsy diagnosis. Common complications of epilepsy include: Status epilepticus, sudden unexpected death, submersion Injury, dental injury, burns, fractures, head injury, soft tissue injury and motor vehicle accidents.

Natural History, Complications, and Prognosis

Natural History

  • If left untreated, 23% to 71% of patients with a single unprovoked seizure may experience it again within 2 years.
  • After the second unprovoked seizure, the chance of having another seizure increase to 73%.
  • Recurrent seizures with no underlying illness emphasis on epilepsy diagnosis.
  • In contrast to adolescent onset epilepsy syndromes most of the childhood onset epilepsy such as benign childhood epilepsy with centrotemporal spikes will go to remission.
  • There is no evidence demonstrating the effect of medical therapy on natural history of epilepsy.[1]

Complications

Prognosis

  • Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
  • Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
  • The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
  • [Subtype of disease/malignancy] is associated with the most favorable prognosis.
  • The prognosis varies with the [characteristic] of the tumor; [subtype of disease/malignancy] has the most favorable prognosis.

References

  1. ↑ Samuels, Martin (2017). Samuels's Manual of neurologic therapeutics. Philadelphia: Wolters Kluwer Health. ISBN 9781496360311.
  2. ↑ Mattle, Heinrich (2017). Fundamentals of neurology : an illustrated guide. Stuttgart New York: Thieme. ISBN 9783131364524.
  3. ↑ Samuels, Martin (2017). Samuels's Manual of neurologic therapeutics. Philadelphia: Wolters Kluwer Health. ISBN 9781496360311.
  4. ↑ Buck D, Baker GA, Jacoby A, Smith DF, Chadwick DW (April 1997). "Patients' experiences of injury as a result of epilepsy". Epilepsia. 38 (4): 439–44. PMID 9118849.
  5. ↑ van den Broek M, Beghi E (January 2004). "Morbidity in patients with epilepsy: type and complications: a European cohort study". Epilepsia. 45 (1): 71–6. PMID 14692910.
  6. ↑ Pack AM, Olarte LS, Morrell MJ, Flaster E, Resor SR, Shane E (April 2003). "Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs". Epilepsy Behav. 4 (2): 169–74. PMID 12697142.
  7. ↑ Beghi E, Cornaggia C (September 2002). "Morbidity and accidents in patients with epilepsy: results of a European cohort study". Epilepsia. 43 (9): 1076–83. PMID 12199734.
  8. ↑ Hansotia P, Broste SK (1993). "Epilepsy and traffic safety". Epilepsia. 34 (5): 852–8. PMID 8404737.
  9. ↑ Verrier, Richard L.; Pang, Trudy D.; Nearing, Bruce D.; Schachter, Steven C. (2020). "The Epileptic Heart: Concept and clinical evidence". Epilepsy & Behavior. 105: 106946. doi:10.1016/j.yebeh.2020.106946. ISSN 1525-5050.
Retrieved from "https://www.wikidoc.org/index.php?title=Epilepsy_natural_history,_complications_and_prognosis&oldid=1682864"